Literature DB >> 29446840

Uncontrolled blood pressure affects atrial remodeling and adverse clinical outcome in paroxysmal atrial fibrillation.

Masashi Kamioka1, Naoko Hijioka1, Yoshiyuki Matsumoto1, Minoru Nodera1, Takashi Kaneshiro1, Hitoshi Suzuki1, Yasuchika Takeishi1.   

Abstract

BACKGROUND: To investigate the impact of uncontrolled blood pressure (BP) on left atrial (LA) remodeling and clinical outcome after pulmonary vein isolation (PVI) in paroxysmal atrial fibrillation (AF).
METHODS: One hundred and one symptomatic paroxysmal AF patients (85 males, 62.2 ± 8.4-year-old) who underwent successful PVI were classified as follows: group 1 (n = 46), no hypertension (HTN); group 2 (n = 36), HTN with controlled BP; and group 3 (n = 19), HTN with uncontrolled BP. Uncontrolled BP was defined as BP > 140/90 mm Hg. LA dimension was measured by echocardiography before and 6 months after PVI. LA wall thickness along the ablation line was measured using computed tomography prior to PVI. Cox regression analysis was performed for the prediction of recurrence.
RESULTS: LA wall thickness in groups 2 and 3 was greater than that of group 1, except for the anterior right superior pulmonary vein (PV) and posterior left inferior PV. Kaplan-Meier analysis revealed a significantly higher recurrence in group 3 (52.6%). LA dimension only increased in group 3 (38.2 ± 5.6 mm to 41.3 ± 6.2 mm, P = 0.022). At the second procedure, all group 3 recurrent patients showed substrate degradation (low voltage area and/or dense scar formation) and required substrate modification. Uncontrolled BP was an independent risk factor for recurrence (hazard ratio: 2.350, P = 0.033).
CONCLUSIONS: HTN induced heterogeneous LA hypertrophy regardless of whether HTN was controlled. Uncontrolled BP promoted atrial remodeling, and is therefore a strong predictor for recurrence of AF after PVI.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; hypertension; remodeling; uncontrolled blood pressure

Mesh:

Year:  2018        PMID: 29446840     DOI: 10.1111/pace.13311

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  12 in total

1.  Multiparametric assessment of left atrial remodeling using 18F-FDG PET/CT cardiac imaging: A pilot study.

Authors:  Michael Ghannam; Hong Jun Yun; Edward P Ficaro; Hamid Ghanbari; John J Lazarus; Matthew Konerman; Ravi V Shah; Richard Weinberg; James R Corbett; Hakan Oral; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2018-09-06       Impact factor: 5.952

2.  Heterogeneity in the left atrial wall thickness contributes to atrial fibrillation recurrence after catheter ablation.

Authors:  Yosuke Nakatani; Tamotsu Sakamoto; Yoshiaki Yamaguchi; Yasushi Tsujino; Naoya Kataoka; Koichiro Kinugawa
Journal:  Heart Vessels       Date:  2018-06-05       Impact factor: 2.037

Review 3.  The effects of cardiac stretch on atrial fibroblasts: analysis of the evidence and potential role in atrial fibrillation.

Authors:  Xixiao Li; Anna Garcia-Elias; Begoña Benito; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

4.  Ablation of Atrial Fibrillation in Patients with Hypertension-An Analysis from the German Ablation Registry.

Authors:  Maura M Zylla; Matthias Hochadel; Dietrich Andresen; Johannes Brachmann; Lars Eckardt; Ellen Hoffmann; Karl-Heinz Kuck; Thorsten Lewalter; Burghard Schumacher; Stefan G Spitzer; Stephan Willems; Jochen Senges; Hugo A Katus; Dierk Thomas
Journal:  J Clin Med       Date:  2020-07-27       Impact factor: 4.241

5.  Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke.

Authors:  Bilonda K Paulin; Kabulo K Cedric; Abdelhakam G Tamomh; Yang Dong Hui
Journal:  Int J Health Sci (Qassim)       Date:  2019 Nov-Dec

6.  Visit-to-Visit Blood Pressure Variability Predicts Atrial Fibrillation Recurrence After Pulmonary Vein Isolation in Patients With Hypertension and Atrial Fibrillation.

Authors:  Masashi Kamioka; Takashi Kaneshiro; Naoko Hijioka; Kazuaki Amami; Minoru Nodera; Shinya Yamada; Yasuchika Takeishi
Journal:  Circ Rep       Date:  2021-03-18

7.  The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial.

Authors:  Willy Weng; Rajin Choudhury; John Sapp; Anthony Tang; Jeff S Healey; Isabelle Nault; Lena Rivard; Isabelle Greiss; Jordan Bernick; Ratika Parkash
Journal:  BMC Cardiovasc Disord       Date:  2021-09-16       Impact factor: 2.298

Review 8.  Efficacy of treatment methods for uncontrolled hypertension and its effects on atrial fibrillation: A systematic narrative review.

Authors:  Abdulaziz A Alodhayani; Abdullah Alkhushail; Mashhor Alhantoushi; Saad M Alsaad; Turky H Almigbal; Khalid Alotaibi; Mohammed A Batais; Abdulrahman Altheaby; Sultan Al Dalbhi; Yasser Alghamdi
Journal:  Int J Health Sci (Qassim)       Date:  2019 Nov-Dec

9.  Procedural characteristics of pulmonary vein isolation with high-power short-duration setting compared to conventional setting.

Authors:  Naoko Hijioka; Takashi Kaneshiro; Takeshi Nehashi; Kazuaki Amami; Minoru Nodera; Shinya Yamada; Masashi Kamioka; Takafumi Ishida; Yasuchika Takeishi
Journal:  BMC Cardiovasc Disord       Date:  2022-01-24       Impact factor: 2.298

10.  Atrial Remodeling in Atrial Fibrillation. Comorbidities and Markers of Disease Progression Predict Catheter Ablation Outcome.

Authors:  Judit Szilágyi; László Sághy
Journal:  Curr Cardiol Rev       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.